VRPX (OTC)
VIRPAX PHARMS INC
$0.011100
+0.010600 (+2,120.00%)
Prev close: $0.000500
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Gerald W. Bruce
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.13M
- Employees
- 7
- P/E (TTM)
- -2.63
- P/B (TTM)
- 0.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-20.00 | $-6.89 | -13.1150 | -190.49% |
|
Sep 2024 (Q3)
|
$-10.75 | $-13.77 | +3.0200 | +21.93% |
|
Jun 2024 (Q2)
|
$-43.75 | $-39.02 | -4.7350 | -12.14% |
|
Dec 2023 (Q4)
|
$-97.50 | $-68.85 | -28.6500 | -41.61% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $13.37M |
| Research and Development | $5.81M |
| Other Operating Expenses | $7.56M |
| Operating Income/Loss | -$13.37M |
| Income/Loss From Continuing Operations After Tax | -$13.24M |
| Income/Loss From Continuing Operations Before Tax | -$13.24M |
| Net Income/Loss | -$13.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.24M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $3.85M |
| Preferred Stock Dividends And Other Adjustments | $3.85M |
| Basic Earnings Per Share | -$8.83 |
| Diluted Earnings Per Share | -$7.24 |
| Basic Average Shares | 7,806,037 |
| Diluted Average Shares | 2,594,504 |
| Assets | $304.16K |
| Current Assets | $304.16K |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.36M |
| Current Liabilities | $2.36M |
| Noncurrent Liabilities | $0.00 |
| Equity | -$2.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$2.05M |
| Liabilities And Equity | $304.16K |
| Net Cash Flow From Operating Activities | -$16.85M |
| Net Cash Flow From Operating Activities, Continuing | -$16.85M |
| Net Cash Flow | -$3.01M |
| Net Cash Flow, Continuing | -$3.01M |
| Comprehensive Income/Loss | -$13.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.24M |
| Other Comprehensive Income/Loss | $0.00 |